Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-22-014.html
december 2, 2021pa-20-185 - nih research project grant (parent r01 clinical trial not allowed) not-ai-22-009 - notice of early expiration of pa-19-077, â€œaccelerating malaria vaccine discovery (r01 clinical trial not allowed)national institute of allergy and infectious diseases (niaid)the purpose of this notice of special interest (nosi) is to inform potential applicants about an area of special interest to niaid on early phase translational research that will generate new malaria vaccine candidates with desirable features suitable for further downstream development and clinical evaluation. this nosi encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially plasmodium falciparum and plasmodium vivax.background and research objectivesthis nosi is intended to encourage research to identify, characterize, credential and validate new protective antigens or vaccine candidates with appropriate assay systems or animal models. for purposes of this nosi, protective antigens or vaccine candidates should demonstrate appropriate functional characteristics, such as prevention of infection, amelioration of disease, interruption of transmission, or prevention of relapse, or other functional features, when applicable.examples of research topics include, but are not limited to:application and submission informationthis notice applies to application receipt dates on or after february 5, 2022 and subsequent receipt dates through january 7, 2025.submit applications for this initiative using one of the following funding opportunity announcements (foas) or any reissues of these announcements.all instructions in the sf424 (r&r) application guide and the funding opportunity announcement used for submission must be followed, with the following additions:applications nonresponsive to terms of this nosi will not be considered for the nosi initiative.scientific/research contact(s)annie mo, ph.d. national institute of allergy and infectious diseases (niaid) telephone: 240-627-3320 email: moa@niaid.nih.govfinancial/grants management contact(s) vandhana khurana national institute of allergy and infectious diseases (niaid) telephone: 240-669-2966 email: khuranav@niaid.nih.govweekly toc for this announcement nih funding opportunities and noticesnote: for help accessing pdf, rtf, ms word, excel, powerpoint, audio or video files, see help downloading files.